Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique

Launched by DAN LIU · Nov 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new method for diagnosing and treating diseases in the mediastinum, which is the area in the chest between the lungs. The researchers want to find out if using ultrasound to guide a special technique for accessing this area can help doctors make better diagnoses and treat conditions, whether the diseases are benign (non-cancerous) or malignant (cancerous). Participants will undergo a procedure that involves taking a small tissue sample and potentially using techniques like freezing or lasers to remove or destroy abnormal growths.

To be eligible for the trial, participants should be between 65 and 74 years old and need to have specific abnormalities in their mediastinum shown by imaging tests. They must also be able to handle general anesthesia and a procedure called bronchoscopy, where doctors look at the lungs and airways. Unfortunately, if a patient already has a clear diagnosis from other tests or cannot tolerate the anesthesia, they won’t be able to join the study. Participants in the trial can expect close monitoring and care throughout the process, and the research aims to determine if this new approach provides better outcomes compared to traditional methods.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Radiographic abnormalities of mediastinum
• • Can tolerate general anesthesia
• • Can tolerate bronchoscopy and has the condition to have mediastinal biopsy and treatment
• Exclusion Criteria:
• • Imaging or other tests can make a definitive diagnosis
• • Cannot tolerate general anesthesia or tracheoscopic surgery
• • Patients cannot sign informed consent forms